Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1997 | 12-1996 | 12-1995 | 12-1994 | 12-1993 | |
| Assets | |||||
| Current Assets | |||||
| Marketable Securities | 600 | 1,000 | 80 | 5,060 | 140 |
| Receivables | 5,030 | 9,540 | 13,500 | 7,710 | 4,540 |
| Inventories | 580 | 1,180 | 1,480 | 4,450 | 2,470 |
| Other current assets | 1,450 | 4,550 | 2,310 | 3,270 | 470 |
| TOTAL | $7,660 | $16,270 | $17,370 | $20,490 | $7,620 |
| Non-Current Assets | |||||
| Investments And Advances | 5,160 | 1,300 | 0 | 0 | 0 |
| Other Non-Current Assets | 6,870 | 1,880 | 1,590 | 0 | 0 |
| TOTAL | $12,030 | $3,180 | $1,590 | $0 | $0 |
| Total Assets | $27,150 | $22,200 | $22,020 | $22,250 | $9,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,560 | 350 | 320 | 190 | 70 |
| Other current liabilities | 80 | 80 | 910 | 60 | 1,020 |
| TOTAL | $8,810 | $7,540 | $7,080 | $8,420 | $7,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 250 | 160 | 4,000 | 0 | 60 |
| Other Non-Current Liabilities | 0 | 1,030 | 0 | 0 | 0 |
| TOTAL | $250 | $1,190 | $4,000 | $0 | $60 |
| Total Liabilities | $9,070 | $8,740 | $11,080 | $8,420 | $7,060 |
| Shareholders' Equity | |||||
| Common Shares | 10 | 10 | 6 | 6 | 2 |
| Retained earnings | -23,130 | -11,900 | -2,760 | 1,100 | 790 |
| Other shareholders' equity | 2,700 | 0 | -6 | 4 | 8 |
| TOTAL | $18,070 | $13,460 | $10,930 | $13,820 | $1,720 |
| Total Liabilities And Equity | $27,140 | $22,200 | $22,010 | $22,240 | $8,780 |